ARCT - Arcturus Therapeutics EPS misses by $0.44 misses on revenue November, 09 2020 04:06 PM Arcturus Therapeutics Ltd. Arcturus Therapeutics (ARCT): Q3 GAAP EPS of -$0.92 misses by $0.44.Revenue of $2.3M (-30.7% Y/Y) misses by $0.76M.Shares +1.01%.Press Release For further details see: Arcturus Therapeutics EPS misses by $0.44, misses on revenue